Nov 8 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced ...

The list price of a vial of rapid-acting NovoLog, one of the most widely used insulin products, will fall to $72, from $289. The new price was still about twice what it was when NovoLog was ...

Novo Nordisk has developed a new version of the insulin analogue, called Fiasp, which added another DKK 1.6 billion to the fast-acting insulin pot last year and has patent protection to 2030.

According to Novo Nordisk, Levemir FlexPen will be discontinued on April 1, 2024, with supply disruptions expected by mid-January 2024. Levemir vials will be discontinued on December 31, 2024.

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding answers from the pharmaceutical giant they say left patients without an ...

Novo Nordisk said Tuesday that its popular fast-acting insulins NovoLog and NovoLog Mix 70/30 will cost $72.34 for a single vial and $139.71 for a pen, a 75% decrease in price.

Novo Nordisk plans to slash the U.S. list prices for several of its insulin drugs by as much as 75%, the company said on Tuesday. The move follows Eli Lilly's announcement earlier this month that ...

Novo Nordisk said the price of its fast-acting insulins, NovoLog and NovoLog Mix 70/30, will be reduced by 75% to $72.34 per vial and $139.71 for a pen. Its long-acting insulin, ...

Danish pharmaceutical company Novo Nordisk announced on Tuesday it would be lowering the prices of some of its insulin products in the U.S. by up to 75 percent, becoming the second company to take ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.. The Danish drugmaker said Tuesday that pre-filled pens ...

Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health insurers. Hotspots ranked Start the day smarter ☀️ Funniest cap ...

The prices for Novo Nordisk products Novolin and Levemir, longer-acting forms of insulin, will be cut down by 65 percent, dropping to $107.85 and $48.20 in their vial forms, respectively.